Sometimes the patents read ambiguously and in code language.

(Originally published on November 24, 2021)

NOTE: Sometimes the patents read ambiguously and in code language. They refer to the “Spike Protein” which is synonymous with the “Glycoprotein S”. Other times the descriptions could be referring to RNA and DNA changes, like coding new genetic sequences using “cDNA”. They sometimes read with words “in some embodiment’s” which likely means in some vials. 

TABLE OF CONTENTS:

Moderna

Pfizer

Janssen (J & J)

Oxford University

AstraZeneca

GlaxoSmithKline (GSK)

Novavax

Gilead

MODERNA

“Lentivirus shows up in a couple of patents: Modernatx, Inc., Sars-Cov-2 mRNA domain vaccines November 4th, 2021. 

The “Lentivirus” or “Lentiviral vector” is messenger RNA (mRNA) which contains the SARS, MERS, HIV 1-3 and SRV-1 Gain-and-Loss-of-Function bioweapons. 

Patent: https://patents.google.com/patent/WO2021159040A2

Moderna: Delivery and formulation ofengineered nucleic acids
Patent: https://patents.google.com/patent/US10898574B2

Lentivirus

cDNA (Complimentary DNA for patent eligibility using artificial genetic sequences). 

Deletions (Deletions of genetic codes on particular genetic lineages in humans)

Open Reading Frame (ORF) – No stop codon (Continuous production of spike proteins of synthetic DNA)

PFIZER

Pfizer Covid-19 vaccine patent:

https://patents.google.com/patent/WO2021213945A1

Lentivirus (no mention)

cDNA

Deletions

Open Reading Frame (ORF)

JANSSEN
Janssen (Johnson and Johnson) Coronavirus vaccine:
https://patents.google.com/patent/WO2021155323A1

Lentivirus

pcDNA (plasmid cloning DNA)

Deletion

ORF

OXFORD UNIVERSITY
Oxford University: Compositions and methods for inducing an immune response:
https://patents.google.com/patent/WO2021181100A1

Lentivirus

cDNA

Deletion (See E1 and E3 Above)

ASTRAZENECA
AstraZeneca: Dapagliflozin and Ambrisentan for the prevention and treatment of covid-19
https://patents.google.com/patent/WO2021219691A1/en
Lentivirus Not mentioned in the patent
cDNA Not mentioned in the patent
Deletion Not mentioned in the patent
ORF Not mentioned in the patent

GLAXOSMITHKLINE
GlaxoSmithKline Biologicals Sa:Sars cov-2 spike protein construct
https://patents.google.com/patent/WO2021209970A1
cDNA and Deletion mentioned in the patent 

ORF Not mentioned in the patent

Lentivirus Not mentioned in the patent

NOVAVAX
Novavax:Coronavirus vaccine
https://patents.google.com/patent/US20210228709A1
Lentivirus Not mentioned in the patent
cDNA Not mentioned in the patent

Deletion

ORF Not mentioned in the patent

GILEAD
Gilead Sciences Inc:Methods for treating sars cov-2 infections
https://patents.google.com/patent/US20210283150A1

Lentivirus Not mentioned in the patent
cDNA Mentioned but seems only to refer to the formula.
Deletion Mentioned for mice. Probably just for preparation purposes.
ORF Not mentioned in the patent

Other related sources:
What are Lentiviral Vectors https://biology.kenyon.edu/slonc/gene-web/Lentiviral/Lentivi2.html
Gene patents https://medlineplus.gov/genetics/understanding/testing/genepatents/
US Supreme Court ruling on cDNA https://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf